MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Environmental Treatment for Seasonal Affective Disorder (SAD)

Not Applicable
Completed
Conditions
Seasonal Affective Disorder
Interventions
Device: Litebook treatment devices
Device: Inactivated negative ion generator
First Posted Date
2005-08-31
Last Posted Date
2013-03-06
Lead Sponsor
Yale University
Target Recruit Count
26
Registration Number
NCT00139997
Locations
🇨🇦

Douglas Hospital Research Centre, Montreal, Quebec, Canada

🇳🇱

University Medical Center Groningen, Groningen, RB, Netherlands

🇨🇦

University of British Columbia, Vancouver, British Columbia, Canada

and more 2 locations

Usefulness of Selegiline as an Aid to Quit Smoking - 1

Phase 2
Completed
Conditions
Tobacco Use Cessation
Interventions
Drug: Placebo
First Posted Date
2005-08-11
Last Posted Date
2015-03-31
Lead Sponsor
Yale University
Target Recruit Count
101
Registration Number
NCT00129311
Locations
🇺🇸

PRISM, New Haven, Connecticut, United States

Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain

Phase 1
Completed
Conditions
Smoking
Nicotine Dependence
Interventions
First Posted Date
2005-08-11
Last Posted Date
2020-12-03
Lead Sponsor
Yale University
Target Recruit Count
40
Registration Number
NCT00129246
Locations
🇺🇸

Yale University School of Medicine Substance Abuse Treatment Unit, New Haven, Connecticut, United States

Treatment of Preterm Labor With 17 Alpha-hydroxyprogesterone Caproate

Not Applicable
Withdrawn
Conditions
Premature Birth
Premature Labor
First Posted Date
2005-07-18
Last Posted Date
2012-09-19
Lead Sponsor
Yale University
Registration Number
NCT00120640

Targeted Interventions for Weight-Concerned Smokers

Phase 2
Completed
Conditions
Nicotine Dependence
Interventions
First Posted Date
2005-03-15
Last Posted Date
2013-03-05
Lead Sponsor
Yale University
Target Recruit Count
172
Registration Number
NCT00105482
Locations
🇺🇸

Yale University School of Medicine Substance Abuse Treatment Unit, New Haven, Connecticut, United States

Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Phase 1
Completed
Conditions
Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms
First Posted Date
2005-03-04
Last Posted Date
2016-12-15
Lead Sponsor
Yale University
Target Recruit Count
20
Registration Number
NCT00104975
Locations
🇺🇸

Yale Cancer Center, New Haven, Connecticut, United States

Framing Messages for Smoking Cessation With Bupropion - 6

Not Applicable
Completed
Conditions
Tobacco Use Disorder
Interventions
Behavioral: Smoking Abstinence Program
First Posted Date
2005-03-02
Last Posted Date
2013-08-09
Lead Sponsor
Yale University
Target Recruit Count
252
Registration Number
NCT00104598
Locations
🇺🇸

Substance Abuse Treatment Unit, New Haven, Connecticut, United States

Insulin Resistance Intervention After Stroke Trial

Phase 3
Completed
Conditions
Stroke
Myocardial Infarction
Diabetes
Interventions
Drug: placebo
First Posted Date
2004-09-22
Last Posted Date
2020-04-27
Lead Sponsor
Yale University
Target Recruit Count
3876
Registration Number
NCT00091949
Locations
🇺🇸

Ohio State University, Columbus, Ohio, United States

🇺🇸

University of South Alabama, Mobile, Alabama, United States

🇺🇸

Shanti Clinical Trials (NINDS-CRC site), Colton, California, United States

and more 177 locations

Aminocamptothecin in Treating Patients With T-cell Lymphoma

Phase 2
Completed
Conditions
Lymphoma
First Posted Date
2004-08-11
Last Posted Date
2013-07-26
Lead Sponsor
Yale University
Target Recruit Count
12
Registration Number
NCT00002635
Locations
🇺🇸

Yale Comprehensive Cancer Center, New Haven, Connecticut, United States

🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

🇺🇸

New England Medical Center Hospital, Boston, Massachusetts, United States

Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer

Phase 3
Completed
Conditions
Carcinoma of Unknown Primary
Head and Neck Cancer
First Posted Date
2004-08-10
Last Posted Date
2013-07-25
Lead Sponsor
Yale University
Registration Number
NCT00002507
Locations
🇺🇸

Yale Comprehensive Cancer Center, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath